Wells Fargo’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.5K Hold
1,338
﹤0.01% 5791
2025
Q1
$1.69K Hold
1,338
﹤0.01% 5712
2024
Q4
$3.04K Sell
1,338
-2,180
-62% -$4.95K ﹤0.01% 5634
2024
Q3
$12.2K Buy
3,518
+1,597
+83% +$5.52K ﹤0.01% 5346
2024
Q2
$9.75K Sell
1,921
-20
-1% -$102 ﹤0.01% 5369
2024
Q1
$16.4K Sell
1,941
-51
-3% -$432 ﹤0.01% 5247
2023
Q4
$8.16K Sell
1,992
-700
-26% -$2.87K ﹤0.01% 5438
2023
Q3
$8.08K Buy
2,692
+202
+8% +$606 ﹤0.01% 5477
2023
Q2
$76.9K Buy
2,490
+836
+51% +$25.8K ﹤0.01% 4924
2023
Q1
$81.9K Buy
1,654
+329
+25% +$16.3K ﹤0.01% 4626
2022
Q4
$32.6K Sell
1,325
-34
-3% -$836 ﹤0.01% 4743
2022
Q3
$90K Buy
1,359
+166
+14% +$11K ﹤0.01% 4376
2022
Q2
$50K Buy
1,193
+111
+10% +$4.65K ﹤0.01% 4740
2022
Q1
$55K Sell
1,082
-155
-13% -$7.88K ﹤0.01% 5275
2021
Q4
$74K Buy
1,237
+358
+41% +$21.4K ﹤0.01% 5351
2021
Q3
$44K Buy
879
+25
+3% +$1.25K ﹤0.01% 5368
2021
Q2
$49K Sell
854
-1,184
-58% -$67.9K ﹤0.01% 5250
2021
Q1
$116K Sell
2,038
-4,807
-70% -$274K ﹤0.01% 5083
2020
Q4
$465K Buy
6,845
+2,346
+52% +$159K ﹤0.01% 4483
2020
Q3
$1.14M Buy
4,499
+544
+14% +$138K ﹤0.01% 3676
2020
Q2
$665K Buy
3,955
+2,915
+280% +$490K ﹤0.01% 4016
2020
Q1
$73K Buy
1,040
+707
+212% +$49.6K ﹤0.01% 4996
2019
Q4
$21K Hold
333
﹤0.01% 5437
2019
Q3
$20K Sell
333
-9
-3% -$541 ﹤0.01% 5449
2019
Q2
$20K Buy
342
+9
+3% +$526 ﹤0.01% 5435
2019
Q1
$22K Hold
333
﹤0.01% 5408
2018
Q4
$18K Sell
333
-637
-66% -$34.4K ﹤0.01% 5450
2018
Q3
$56K Buy
970
+14
+1% +$808 ﹤0.01% 5277
2018
Q2
$56K Hold
956
﹤0.01% 5300
2018
Q1
$45K Buy
956
+200
+26% +$9.41K ﹤0.01% 5301
2017
Q4
$44K Buy
756
+356
+89% +$20.7K ﹤0.01% 5299
2017
Q3
$25K Buy
400
+67
+20% +$4.19K ﹤0.01% 5339
2017
Q2
$21K Hold
333
﹤0.01% 5305
2017
Q1
$21K Buy
333
+66
+25% +$4.16K ﹤0.01% 5343
2016
Q4
$10K Hold
267
﹤0.01% 5457
2016
Q3
$10K Buy
+267
New +$10K ﹤0.01% 5440